Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood

Previous
Previous

Veravas Improves Diagnostic Tests by Purifying Samples

Next
Next

VeraBIND Tau is being developed jointly with Veravas, Inc. and Phanes Biotech, Inc.